Competition Bureau probes Well Health
Issue is whether acquisitions are lessening competition for AI transcription and medical-record software.
Category: Healthcare
Well Health sees opportunity in healthcare gaps
As Canada’s healthcare system struggles to keep up with ever growing demands, three homegrown players continue to find opportunity byContinue Reading
Well Health Technologies invests in Canadian healthcare
From six BC clinics in 2018, it is the largest owner of primary care clinics in Canada.
Pfizer has appeal for patient investors
Tariffs will add to share price pressure, but dividends keep rising and drug pipeline promising.
Telus, Loblaw, Well Health take aim at healthcare opportunities
Buying up outpatient clinics and selling practice management software to doctors creating new streams of revenue.
Weight loss drug war heats up
Pfizer and Roche have released promising early stage results, but Novo Nordisk and Eli Lilly have a big head start.
Medtech finds AI applications
Artificial intelligence is making its mark in medical technology applications.
Intuitive Surgical puts AI to work
Its 5th generation da Vinci robotic surgery tool has 10,000 times more processing power that generation 4.
Eli Lilly, Novo Nordisk soar with demand for weight loss drugs
Lilly has more than doubled in a year, while Denmark’s Novo Nordisk is up by two-thirds.
Weight loss drug era just starting: Analysts
Elil Lilly and Novo Nordisk have head start on market projected to hit $100B in US by 2030.
Adam Mayers 
You must be logged in to post a comment.